Literature DB >> 3137204

Radiation responses of subrenally transplanted syngeneic and allogeneic mouse fibrosarcomas.

S Sato1, A Ootsuyama, H Tanooka.   

Abstract

The radiation responses of two tumor types transplantable into C3H/He mice and differing in radiosensitivity, i.e., 3-methylcholanthrene (MCA)-induced fibrosarcoma and NFSa fibrosarcoma, were investigated using the subrenal capsule assay. Subrenal tumor growth was histologically confirmed. Volume regression and regrowth of subrenal capsule-implanted and subcutaneously implanted tumors after X-irradiation were compared. No difference was found in tumor growth speed (volume doubling time: 1.2-1.3 days) between the subrenal transplants into C3H/He mice, syngeneic to the tumor grafts, and those into immuno-incompetent C57BL mice, allogeneic to the tumor grafts. The tumor growth rates for subrenal capsule transplants were 1.7- to 1.8-fold higher than those for subcutaneous transplants of the same tumor type. A marked difference was found in the radiation responses of the two tumor types by the subrenal capsule assay, i.e., tumor regrowth time following 20 Gy irradiation was more than 8 days for MCA-induced fibrosarcoma and 4.5-5.4 days for radioresistant NFSa fibrosarcoma. These values correlate well with the estimated radiation sensitivities of these tumors.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3137204      PMCID: PMC5917585          DOI: 10.1111/j.1349-7006.1988.tb02234.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  13 in total

Review 1.  Potential methods for predicting tumor radiocurability.

Authors:  L J Peters; W A Brock; T Johnson; R E Meyn; P J Tofilon; L Milas
Journal:  Int J Radiat Oncol Biol Phys       Date:  1986-04       Impact factor: 7.038

2.  Predicting radiocurability.

Authors:  L J Peters; W Brock; T Johnson
Journal:  Cancer       Date:  1985-05-01       Impact factor: 6.860

3.  Inherent cellular radiosensitivity as a basic concept for human tumor radiotherapy.

Authors:  B Fertil; E P Malaise
Journal:  Int J Radiat Oncol Biol Phys       Date:  1981-05       Impact factor: 7.038

4.  Subrenal capsule assay applied to examine the sensitivity of allogenic mouse fibrosarcoma to hyperthermia, chemotherapeutic drugs or combined treatment.

Authors:  S Sato; A Ootsuyama; M Hamada; H Tanooka
Journal:  Int J Hyperthermia       Date:  1987 Mar-Apr       Impact factor: 3.914

5.  Independent effect of a mixed-beam regimen of fast neutrons and gamma rays on a murine fibrosarcoma.

Authors:  K Ando; S Koike; N Fukuda; C Kanehira
Journal:  Radiat Res       Date:  1984-04       Impact factor: 2.841

6.  A four-day subrenal capsule assay for testing the effectiveness of anticancer drugs against human tumors.

Authors:  F A Levi; J P Blum; G Lemaigre; C Bourut; A Reinberg; G Mathé
Journal:  Cancer Res       Date:  1984-06       Impact factor: 12.701

7.  Comparison between macroscopic and microscopic evaluation of tumour responsiveness using the subrenal capsule assay.

Authors:  M B Edelstein; H H Fiebig; T Smink; L M Van Putten; C Schuchhardt
Journal:  Eur J Cancer Clin Oncol       Date:  1983-07

8.  Experimental radiation therapy and apparent radioresistance of autochthonous tumors subcutaneously induced with 3-methylcholanthrene in mice.

Authors:  H Tanooka; H Hoshino; K Tanaka; M Nagase
Journal:  Cancer Res       Date:  1980-07       Impact factor: 12.701

9.  Initial clinical trials of the subrenal capsule assay as a predictor of tumor response to chemotherapy.

Authors:  T W Griffin; A E Bogden; S D Reich; D Antonelli; R E Hunter; A Ward; D T Yu; H L Greene; M E Costanza
Journal:  Cancer       Date:  1983-12-15       Impact factor: 6.860

10.  Growth of human tumor xenografts implanted under the renal capsule of normal immunocompetent mice.

Authors:  A E Bogden; P M Haskell; D J LePage; D E Kelton; W R Cobb; H J Esber
Journal:  Exp Cell Biol       Date:  1979
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.